You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Zepbound ® (tirzepatide) injection
2.5 mg/ 5 mg/ 7.5 mg/ 10 mg/ 12.5 mg/ 15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can patients use Zepbound® (tirzepatide) if they have undergone or are awaiting an organ transplant?
No information is available for patients who have undergone or are awaiting an organ transplant.
See important safety information, including boxed warning, in the attached prescribing information.
Organ Transplant
No information is available on the use of tirzepatide in patients who have a transplanted organ or who are awaiting an organ transplant. However, patients with corneal transplants were eligible to participate in the tirzepatide clinical trial program.
Enclosed Prescribing Information
Date of Last Review: December 19, 2024